The COVID-19 pandemic exposed a structural vulnerability that Africa had long lived with but rarely confronted at scale: its near-total dependence on imported medical and hygiene materials. Masks, surgical gowns, drapes, wipes, filters, and protective clothing—all fundamentally nonwoven products—suddenly became strategic commodities. Border closures, export bans and disrupted logistics transformed what had been low-cost consumables into scarce, high-value assets that governments scrambled to secure.

For the first time, African policy makers and health systems experienced, in real time, what it meant for critical healthcare infrastructure to be embedded in global supply chains over which they had little control. Nonwovens, normally invisible in the background of hospitals and clinics, became as strategically important as pharmaceuticals, oxygen and diagnostic equipment.

In response, a wave of emergency investments swept across the continent. Meltblown and spunbond lines were installed, mask-making capacity expanded and local converters retooled their operations to supply healthcare systems. South Africa, Egypt, Morocco, Kenya, Ethiopia and Nigeria all moved, with varying degrees of coordination, to establish domestic PPE and medical textile production. For the first time, Africa demonstrated that it could, under pressure, build meaningful medical nonwovens capability in months rather than decades.

Today, much of that momentum is at risk. Normalized global supply chains normalize and collapsed prices have left these  emergency lines idled as investors retreat and policy attention shifts elsewhere. Imported masks and gowns once again undercut local production on price. Procurement systems revert to short-term, lowest-cost sourcing. The danger is clear: Africa could slip back into full import dependence.

Yet the strategic logic that drove localization during the pandemic has not disappeared. If anything, it has become stronger. Population growth, rapid urbanization, a rising burden of non-communicable diseases, persistent infectious disease risks, climate-related health shocks and geopolitical uncertainty all point toward structurally higher long-term demand for medical and protective nonwovens. The question is no longer whether Africa will need this capability, but when.

Medical Nonwovens as Strategic Infrastructure

Medical nonwovens are often viewed as consumables that are low-margin, high-volume products best sourced from the cheapest global supplier. COVID-19 revealed a different reality. In times of crisis, they function as critical infrastructure, on par with oxygen plants, pharmaceutical manufacturing and laboratory networks.

Spunbond and SMS fabrics form the backbone of surgical gowns, drapes, caps, shoe covers, and isolation wear, providing controlled barrier properties, breathability and mechanical strength. Meltblown media is the heart of filtration in respirators and medical masks, where fiber diameter, electrostatic charge and pore-size distribution determine particle capture efficiency and pressure drop. Hydroentangled nonwovens underpin wipes, wound-care substrates and surface disinfection systems, combining softness with liquid management and lint-free performance. Specialty needlepunched and composite structures appear in mattress protection, bedding, insulation and even in hospital building envelopes and HVAC filtration.

Each of these materials directly affects infection control, occupational safety and continuity of care. Globally, medical nonwovens are among the fastest-growing segments of the industry, driven by aging populations, stricter infection-control protocols, the expansion of universal healthcare systems and the increasing complexity of clinical environments. In Africa, these drivers are amplified by demographic growth, urban density and the dual burden of communicable and lifestyle-related diseases. The continent is investing heavily in hospitals, laboratories and clinics—yet the technical textile layer that enables these facilities to function safely remains structurally fragile.

From Emergency Lines to Sustainable Platforms

For emergency capacity to evolve into sustainable platforms, the industry must shift from opportunistic PPE manufacturing to integrated medical nonwovens ecosystems. This means designing facilities not as single-product mask lines, but as flexible spunmelt, meltblown, and hydroentanglement platforms capable of serving multiple healthcare applications – from barrier fabrics and wipes to filtration and sterilisation wraps. Dual-use capability, allowing lines to swing between hygiene, medical, and technical grades, becomes essential for maintaining utilisation and resilience.

Regional Hubs and Emerging Platforms

Different parts of Africa already exhibit the building blocks of such ecosystems.

North Africa

In North Africa, Egypt and Morocco have leveraged their strong textile traditions, export-oriented manufacturing bases, and proximity to Europe to build integrated spunbond, meltblown, and garmenting capacity. Alignment with European regulatory frameworks and access to skilled labour position the region as a potential hub for high-specification medical nonwovens serving both African and Mediterranean markets.

Southern Africa

In Southern Africa, South Africa’s established nonwovens industry, combined with pharmaceutical manufacturing and advanced hospital infrastructure, provides a foundation for a regional medical materials platform. The technical capability exists; the missing piece is stable, long-term demand signals that justify sustained investment in medical-grade lines, cleanroom converting, and local test laboratories.

East Africa

In East Africa, Kenya and Ethiopia demonstrated rapid learning curves during COVID-19, scaling mask and PPE production and engaging directly with global OEMs and filtration specialists. Ethiopia’s industrial parks and Kenya’s growing medical device sector could, with appropriate policy support, evolve into vertically integrated healthcare textile clusters.

West Africa

In West Africa, Nigeria’s sheer population scale and healthcare demand make it a compelling long-term anchor market. While power, logistics, and regulatory consistency remain challenges, ongoing investments in pharmaceuticals and diagnostics suggest that local medical consumables will inevitably follow.

Beyond PPE: The Full Medical Nonwovens Spectrum

Public attention during COVID-19 focused almost exclusively on masks and gowns, yet the medical nonwovens opportunity also  includes wound-care substrates, absorbent underpads, sterilization wraps, surgical drapes, filtration media for hospital HVAC and oxygen systems, dialysis and blood filtration components and high-performance wipes for infection control.

As African healthcare systems modernize, demand will grow not only for disposable barrier products, but also for sophisticated materials that support sterile environments, manage fluids, and protect sensitive equipment. Each of these niches require controlled fibre morphology, surface chemistry, and process consistency – precisely the areas where advanced nonwoven technology adds value. Over time, such capabilities can support export into regional and global healthcare markets, particularly for cost-sensitive but quality-critical products.

Policy, Investment and Technology Priorities

A sustainable healthcare nonwovens strategy cannot be built on factory investments alone. It requires alignment across industrial policy, health procurement, standards, and finance.

From a policy perspective, medical nonwovens should be recognised as strategic assets within national health security and industrialisation frameworks. This enables the use of long-term offtake agreements, local content provisions, and strategic stockpiling to create predictable demand.

From a financing perspective, blended-finance structures involving development banks, export credit agencies, and commercial investors can de-risk first-of-a-kind projects. Anchor procurement by large public health systems or regional purchasing platforms can provide the volume commitments needed to justify medical-grade spunmelt and meltblown investments.

From a technology perspective, partnerships with global OEMs and material suppliers must move beyond equipment supply to encompass process optimization, quality systems and product development. Local test and certification laboratories are equally critical, enabling faster qualification cycles and reducing dependence on overseas facilities.

From Crisis Response to Strategic Resilience

Africa’s experience during COVID-19 demonstrated that medical nonwovens are not peripheral consumables; they are foundational components of healthcare systems. The continent proved that it can build capacity under extreme pressure. The challenge now is to institutionalize that capability, to move from reactive crisis response to proactive strategic resilience.

If Africa allows its medical nonwovens base to wither as global prices fall, it will re-enter the next pandemic, climate-related health emergency or geopolitical disruption with the same vulnerabilities it faced in 2020. If, however, it consolidates and upgrades what was built, integrates it into industrial and health policy, and aligns it with long-term investment and procurement strategies, medical nonwovens can become a permanent pillar of healthcare security.

Stay up to date with all Nonwovens Industry content by subscribing to our newsletter .